The evolution of cancer immunotherapy continues to accelerate with the advent of immune checkpoint activators, representing a significant advancement beyond traditional inhibitory approaches. These novel therapeutics are designed to amplify immune responses against malignant cells, creating substantial momentum within the Immune Checkpoints Activators Market as researchers explore new frontiers...